本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

15.24
+0.59004.03%
盘后15.300.0600+0.39%19:58 EDT
成交量:156.60万
成交额:2,379.50万
市值:18.08亿
市盈率:-13.16
高:15.58
开:14.75
低:14.74
收:14.65
数据加载中...
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/25

SEC问询函

Form CORRESP - Correspondence
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals